EC Neurology

Case Report Volume 15 Issue 5 - 2023

Imaging Utility in the Diagnosis of Dejerine-Sottas Disease: Case Report

Halfi Mohamed Ismail*, Zahi Hiba, Fikri Meriem, Jiddane Mohamed and Touarsa Firdaous

Neuroradiology Department, University Hospital of Ibn Sina, Mohamed V University, Rabat, Morocco

*Corresponding Author: Halfi Mohamed Ismail, Neuroradiology Department, University Hospital of Ibn Sina, Mohammed V University, Rabat, Morocco.
Received: March 31, 2023; Published: April 25, 2023



Dejerine-Sottas disease (DSD) also called progressive hypertrophy interstitial neuropathy is a congenital polyneuropathy with results in sensory and motor symptoms. It affects the peripheral nerves of the extremities as well as cranial nerves in 15% of cases. The role of imaging isn't well documented in recent literature due to the important scarcity of this disease. We report the case of a woman with a confirmed diagnosis of DSD as well as the MRI's role in the process. Even though the imagining features aren't specific they may strongly direct the diagnosis into a smaller pool of neuromotor diseases.

Keywords: Dejerine-Sottas Disease; Neuropathy; MRI; Imaging; Congenital; Motor; Sensory

  1. Plante‐Bordeneuve V and Said G. “Dejerine–Sottas disease and hereditary demyelinating polyneuropathy of infancy”. Muscle and Nerve: Official Journal of the American Association of Electrodiagnostic Medicine5 (2002): 608-621.
  2. Maki DD., et al. “MR imaging of Dejerine-Sottas disease”. American Journal of Neuroradiology3 (1999): 378-380.
  3. Satran R. “Dejerine-Sottas disease revisited”. Archives of Neurology2 (1980): 67-68.
  4. Pearce JM. “Dejerine-Sottas disease (progressive hypertrophic polyneuropathy)”. European Neurology2 (2006): 115-117.
  5. Thomas PK., et al. “Autosomal dominant forms of hereditary hypertrophic neuropathy”. InAminoacidopathies, Immunoglobinopathies, Neuro-Genetics and Neuro-Ophthalmology 6 (1972): 210-210.
  6. Thomas PK., et al. “Autosomal dominant forms of hereditary hypertrophic neuropathy”. InAminoacidopathies, Immunoglobinopathies, Neuro-Genetics and Neuro-Ophthalmology 6 (1972): 210-210.
  7. Burger NB., et al. “Dejerine-Sottas syndrome: Prenatal and postnatal postural and motor assessment”. Journal of Obstetrics and Gynaecology3 (2016): 408-409.
  8. Saumya Pandey. “CRISPR-Cas Gene-Editing for Precision-Medicine Based “Neuro-Oncogenomics” in Immunotherapeutic Targeting of Wnt/Frizzled-Toll Like Receptors-Autophagy: Cost-Effective Management of Schizophrenia, Obsessive Compulsive Disorder, Alzheimer’s Disease and Glioblastoma in Genetically Disparate Susceptible Population-Pools in in the Covid-19 Vaccination Era”. EC Clinical and Medical Case Reports2 (2023): 12-14.
  9. Pandey S. “Toll-Like Receptors-Autophagy Immuno-Inflammatory Networks as “Molecular Rheostats” in Hypoxic Tumor Microenvironment in Complex Neurological Diseases Primarily Glioblastoma and Spinal Meningioma: Translational Research Perspective with Public Health Impact in Genetically Susceptible Population-Pools in Covid-19/Omicron Pandemic Era”. EC Neurology7 (2022): 01-02.
  10. Pandey S. “IL-6 induced upregulation of T-type Ca2+ currents and sensitization of DRG nociceptors is attenuated by MNK inhibition: Translational Research Perspective”. Journal of Neurophysiology1 (2020): 305-306.

Halfi Mohamed Ismail., et al. “Imaging Utility in the Diagnosis of Dejerine-Sottas Disease: Case Report”. EC Neurology  15.5 (2023): 88-92.